See also this year's filing and all EDGAR filings for this company.
PDF Report 0001017491_2012_Seelos_Therapeutics_INC.pdf
Logs
| warning | The stock price does not exist | industry.us_generic | {} |
Graph
Absolute values for 0001017491, Seelos Therapeutics INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 8,191,110 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 3,759,950 |
| 2 | PropertyPlantAndEquipmentNet | 4,384,357 |
| 3 | remainder_Assets | 280,193 |
| 4 | LiabilitiesCurrent | 10,020,683 |
| 5 | LiabilitiesNoncurrent | 27,831 |
| 6 | remainder_Liabilities | 1,748,916 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 11,463,448 |
| 9 | ResearchAndDevelopmentExpense | 5,820,763 |
| 10 | remainder_Expenses | 4,996,665 |
| 11 | remainder_Revenues | 4,101,124 |
| 12 | remainder_NetIncome | 62,554 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 16,615,610 |
| 1 | Liabilities | 11,797,430 |
| 2 | Expenses | 22,280,876 |
| 3 | Revenues | 4,101,124 |
| 4 | StockholdersEquity | 4,818,180 |
| 5 | NetIncome | -18,117,198 |
| 6 | ComprehensiveNetIncome | -18,117,198 |
| 7 | BaseVar | 27,428,797 |
| 8 | EconomicCapitalRatiobeforeLimitedLiability | -0.536 |
| 9 | EconomicCapitalRatio | 1.38 |